X
XLinkedinWhatsAppTelegramTelegram
0

EU - Commission clears acquisition of Merial by Sanofi-Aventis

The European Commission has granted clearance under the EU Merger Regulation to the acquisition of sole control of Merial of the US by Sanofi-Aventis of France.
17 September 2009
X
XLinkedinWhatsAppTelegramTelegram
0
The European Commission has granted clearance under the EU Merger Regulation to the acquisition of sole control of Merial of the US by Sanofi-Aventis of France.

Sanofi-Aventis is active in the research, development, manufacturing and marketing of human pharmaceuticals and vaccines, whilst Merial is active in these areas concerning innovative animal pharmaceuticals and vaccines.

The operation was examined under the simplified merger review procedure.

http://europa.eu/rapid/pressReleasesAction.do?reference=MEX/09/0916&format=HTML&aged=0&language=EN&guiLanguage=en

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Log in and sign up on the list